Immunic, Inc. to Participate in Investor and Scientific Conferences in March

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...

Related Keywords

Germany ,United States ,Munich ,Bayern ,Belgium ,Madrid ,Spain ,Boston ,Massachusetts ,Brussels ,Bruxelles Capitale ,American ,Edna Kaplan ,Paula Schwartz ,Duane Nash ,Jessica Breu ,Meeting Of The Society For Virology ,Drug Information Association ,Rx Communications Group ,Prnewswire Immunic Inc ,Nasdaq ,Exchange Commission ,American Academy Of Dermatology ,Immunic Inc ,Annual Roth ,Annual Roth Conference ,Dana Point ,Clinical Trial Supply Europe ,Annual Meeting ,Private Securities Litigation Reform Act ,Annual Report ,Investor Relations ,Immunic ,Nc ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Pharmaceuticals ,Trade Show News ,